Non-Current Liabilities
Other Non-Current Liabilities
Gilead Sciences Other Non-Current Liabilities increased by 3.0% to $1.2B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.2%, from $1.34B to $1.2B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a -0.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026
How to read this metric
Significant increases may indicate rising long-term risks or changes in accounting estimates for long-term commitments.
Detailed definition
Other non-current liabilities include long-term obligations that do not fall into standard categories like long-term deb...
Peer comparison
Standard balance sheet category; varies significantly based on company-specific long-term commitments.
Metric ID:
other_non_current_liabilitiesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.18B | $962M | $976M | $944M | $988M | $1.11B | $1.18B | $1.28B | $1.35B | $924M | $1.28B | $1.4B | $1.42B | $1.4B | $1.3B | $1.34B | $1.29B | $1.18B | $1.17B | $1.2B |
| QoQ Change | — | -18.2% | +1.5% | -3.3% | +4.7% | +11.9% | +6.6% | +8.3% | +6.0% | -31.8% | +38.5% | +9.0% | +1.6% | -1.6% | -7.2% | +3.2% | -3.5% | -8.4% | -1.4% | +3.0% |
| YoY Change | — | — | — | — | -16.0% | +15.0% | +20.8% | +35.3% | +37.0% | -16.5% | +8.6% | +9.2% | +4.7% | +51.1% | +1.2% | -4.2% | -9.0% | -15.3% | -10.0% | -10.2% |
Range$924M – $1.42B
CAGR+0.4%
Avg YoY Growth+6.4%
Median YoY Growth+2.9%
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's other non-current liabilities?
- Gilead Sciences (GILD) reported other non-current liabilities of $1.2B in Q1 2026.
- How has Gilead Sciences's other non-current liabilities changed year-over-year?
- Gilead Sciences's other non-current liabilities decreased by 10.2% year-over-year, from $1.34B to $1.2B.
- What is the long-term trend for Gilead Sciences's other non-current liabilities?
- Over 5 years (2020 to 2025), Gilead Sciences's other non-current liabilities has grown at a -0.8% compound annual growth rate (CAGR), from $1.21B to $1.17B.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified elsewhere.